Steris (STE) Tops Q4 EPS by 15c; Offers FY23 Outlook
Tweet
Share
E-mailGet Alerts STE Hot Sheet
Price: $224.59 -0.69%
EPS Growth %: +8.5%
Financial Fact:
Income (loss) before income tax expense (benefit): 15.84M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +8.5%
Financial Fact:
Income (loss) before income tax expense (benefit): 15.84M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Steris (NYSE: STE) reported Q4 EPS of $2.30, $0.15 better than the analyst estimate of $2.15. Revenue for the quarter came in at $1.38 billion versus the consensus estimate of $1.27 billion.
GUIDANCE:
Steris sees FY2023 EPS of $8.55-$8.75, versus the consensus of $8.05.
For earnings history and earnings-related data on Steris (STE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral
- Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
